Found: 22
Select item for more details and to access through your institution.
Pneumatosis intestinalis induced by targeted therapy.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Severe hepatitis related to immune-checkpoint inhibitor in a patient with non-small-cell lung cancer and pulmonary tuberculosis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Characteristics, treatment patterns, and clinical outcomes in patients with advanced non-small cell lung cancer harboring EGFR exon 20 insertions.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 12, p. 10365, doi. 10.1007/s00432-023-04921-w
- By:
- Publication type:
- Article
Prognosticators of osimertinib treatment outcomes in patients with EGFR-mutant non-small cell lung cancer and leptomeningeal metastasis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 1, p. 5, doi. 10.1007/s00432-022-04396-1
- By:
- Publication type:
- Article
Real-world evidence of the intrinsic limitations of PCR-based EGFR mutation assay in non-small cell lung cancer.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-17394-7
- By:
- Publication type:
- Article
State-of-the-Art Molecular Oncology of Lung Cancer in Taiwan.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 13, p. 7037, doi. 10.3390/ijms23137037
- By:
- Publication type:
- Article
Pharmacokinetics, safety, and efficacy of an alternative dosing regimen of sasanlimab in participants with advanced NSCLC and other malignancies.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241274592
- By:
- Publication type:
- Article
Combined stereotactic radiosurgery and tyrosine kinase inhibitor therapy versus tyrosine kinase inhibitor therapy alone for the treatment of non-small cell lung cancer patients with brain metastases.
- Published in:
- Journal of Neurosurgery, 2022, v. 137, n. 2, p. 563, doi. 10.3171/2021.9.JNS211373
- By:
- Publication type:
- Article
Cytology–Based Specimen Triage for Epidermal Growth Factor Receptor Mutation Testing of Malignant Pleural Effusions in Non–Small Cell Lung Cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.810124
- By:
- Publication type:
- Article
Dynamic immune signatures of patients with advanced non-small-cell lung cancer for infection prediction after immunotherapy.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1269253
- By:
- Publication type:
- Article
Efficacy of different platforms in detecting EGFR mutations using cerebrospinal fluid cell‐free DNA from non‐small‐cell lung cancer patients with leptomeningeal metastases.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 14, p. 1251, doi. 10.1111/1759-7714.14866
- By:
- Publication type:
- Article
Double diaphragmatic contour.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Comparison of the outcome between immunotherapy alone or in combination with chemotherapy in EGFR-mutant non-small cell lung cancer.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-95628-w
- By:
- Publication type:
- Article
Prognostic factors for advanced lung cancer patients with do-not-intubate order in intensive care unit: a retrospective study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Utility of Cerebrospinal Fluid Cell-Free DNA in Patients with EGFR-Mutant Non-Small-Cell Lung Cancer with Leptomeningeal Metastasis.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 2, p. 207, doi. 10.1007/s11523-021-00791-9
- By:
- Publication type:
- Article
Post-Progression Survival in Secondary EGFR T790M-Mutated Non-Small-Cell Lung Cancer Patients With and Without Osimertinib After Failure of a Previous EGFR TKI.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Management strategies for intracranial progression in ALK-positive non-small cell lung cancer: a real-world cohort study.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 165, n. 3, p. 459, doi. 10.1007/s11060-023-04497-y
- By:
- Publication type:
- Article
Is it advisable to perform radiosurgery for EGFR-TKI-controlled brain metastases? A retrospective study of the role of radiosurgery in lung cancer treatment.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 164, n. 2, p. 413, doi. 10.1007/s11060-023-04425-0
- By:
- Publication type:
- Article
Leukoencephalopathy in patients with brain metastases who received radiosurgery with or without whole brain radiotherapy.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 161, n. 1, p. 85, doi. 10.1007/s11060-022-04210-5
- By:
- Publication type:
- Article
Natural history of lung squamous cell brain metastases in patients treated with radiosurgery: a thirty-year experience at a tertiary medical center.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 161, n. 1, p. 135, doi. 10.1007/s11060-022-04153-x
- By:
- Publication type:
- Article
EGFR mutant status and tyrosine-kinase inhibitors affect the GKRS outcomes for NSCLC brain metastases.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 159, n. 3, p. 675, doi. 10.1007/s11060-022-04110-8
- By:
- Publication type:
- Article
IKZF3 amplification frequently occurs in HER2-positive breast cancer and is a potential therapeutic target.
- Published in:
- 2022
- By:
- Publication type:
- journal article